Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,017.20",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "1,017.20",
    "mcapval": "12,648.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Jun 11, 03:30 PM",
    "curr_time": "09:03 AM",
    "last_traded_at": "Jun 11, 03:30 PM IST",
    "bse_nse_vol": "95.26 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-valuation-shifts-signal-changing-market-sentiment-4040087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlivusLifeScien_valuationdot_4040087.png",
        "date": "2026-06-09 08:01:47",
        "description": "Alivus Life Sciences Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects improved price metrics relative to its historical averages and peer group, signalling a potential buying opportunity for investors in the Pharmaceuticals & Biotechnology sector despite a recent downgrade in its overall Mojo Grade to Hold."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4037165",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlivusLifeScien_mojoScore_4037165.png",
        "date": "2026-06-08 10:10:40",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4037205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlivusLifeScien_mojoScore_4037205.png",
        "date": "2026-06-07 10:10:33",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alivus Life Sciences Ltd Gains 1.99%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-gains-199-6-key-factors-driving-the-weeks-momentum-4022691",
        "imagepath": "",
        "date": "2026-05-30 11:04:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>26 May:</strong> Intraday high surge of 7.06% to Rs.1,123</p>\n                    <p><strong>26 May:</strong> Bullish momentum upgrade with technical improvements</p>\n                    <p><strong>27 May:</strong> Downgrade to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>27 May:</strong> Technical momentum shifts to mildly bullish</p>\n                    <p><strong>29 May:</strong> Week closes at Rs.1,056.55 (+1.99%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4016004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_mojoScore_4016004.png",
        "date": "2026-05-27 08:37:31",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 26 May 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate solid fundamentals, evolving market dynamics and technical indicators have prompted a more cautious stance among analysts."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Shift in Technical Momentum Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-shift-in-technical-momentum-amid-mixed-indicator-signals-4015826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4015826.png",
        "date": "2026-05-27 08:05:15",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. While the stock price surged 3.86% on 27 May 2026 to ₹1,088.50, technical indicators present a mixed picture, signalling a transition from a bullish to a mildly bullish trend. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s relative performance against the broader market."
      },
      {
        "title": "Alivus Life Sciences Ltd Surges 7.06% to Day's High of Rs 1123 — Outperforms Sector by 7.21 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-intraday-high-with-706-surge-on-26-may-2026-4013591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_priceRelatedfactors_4013591.png",
        "date": "2026-05-26 10:32:06",
        "description": "The Sensex eked out a modest gain of 0.11% after a volatile session, but Alivus Life Sciences Ltd surged 7.06% on 26 Jun 2026, touching an intraday high of Rs 1123. This 7.21 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4012764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4012764.png",
        "date": "2026-05-26 08:07:02",
        "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, accompanied by a Mojo Score of 70.0, reflects growing investor confidence amid improving price action and technical parameters."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4010016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4010016.png",
        "date": "2026-05-25 08:03:23",
        "description": "Alivus Life Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a modest day decline of 1.87%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This analysis delves into the recent technical parameter changes, evaluating momentum oscillators, moving averages, and volume trends to provide a comprehensive view of the stock’s near-term outlook."
      }
    ],
    "total": 304,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Ltd Valuation Shifts Signal Changing Market Sentiment

2026-06-09 08:01:47

Alivus Life Sciences Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects improved price metrics relative to its historical averages and peer group, signalling a potential buying opportunity for investors in the Pharmaceuticals & Biotechnology sector despite a recent downgrade in its overall Mojo Grade to Hold.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-06-08 10:10:40

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-06-07 10:10:33

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alivus Life Sciences Ltd Gains 1.99%: 6 Key Factors Driving the Week’s Momentum

2026-05-30 11:04:20

Key Events This Week

25 May: Technical momentum shifts amid mixed signals

26 May: Intraday high surge of 7.06% to Rs.1,123

26 May: Bullish momentum upgrade with technical improvements

27 May: Downgrade to Hold amid mixed technical and valuation signals

27 May: Technical momentum shifts to mildly bullish

29 May: Week closes at Rs.1,056.55 (+1.99%) outperforming Sensex

...

Read full news article

Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-05-27 08:37:31

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 26 May 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate solid fundamentals, evolving market dynamics and technical indicators have prompted a more cautious stance among analysts.

Read full news article

Alivus Life Sciences Ltd Sees Shift in Technical Momentum Amid Mixed Indicator Signals

2026-05-27 08:05:15

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. While the stock price surged 3.86% on 27 May 2026 to ₹1,088.50, technical indicators present a mixed picture, signalling a transition from a bullish to a mildly bullish trend. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s relative performance against the broader market.

Read full news article

Alivus Life Sciences Ltd Surges 7.06% to Day's High of Rs 1123 — Outperforms Sector by 7.21 Percentage Points

2026-05-26 10:32:06

The Sensex eked out a modest gain of 0.11% after a volatile session, but Alivus Life Sciences Ltd surged 7.06% on 26 Jun 2026, touching an intraday high of Rs 1123. This 7.21 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift.

Read full news article

Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-05-26 08:07:02

Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, accompanied by a Mojo Score of 70.0, reflects growing investor confidence amid improving price action and technical parameters.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-25 08:03:23

Alivus Life Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a modest day decline of 1.87%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This analysis delves into the recent technical parameter changes, evaluating momentum oscillators, moving averages, and volume trends to provide a comprehensive view of the stock’s near-term outlook.

Read full news article

View All News